NCT04521829

Brief Summary

The aim of this study is to investigate the effect of manipulating the optic flow speed in the virtual environment on the gait pattern during virtual reality (VR) - enhanced treadmill walking in people post-stroke. Furthermore, the study will also investigate if the level of immersion has an effect on the rehabilitation outcomes by manipulating the optic flow speed in two different VR devices: the semi-immersive GRAIL system and the fully-immersive 'Oculus Rift S' HMD. To properly understand the results of the people with a stroke, we will also investigate the effect of manipulating the optic flow speed and the level of immersion on the gait pattern in healthy people. That way, we can investigate whether virtual reality has a different influence on the gait pattern of people with a stroke than in healthy people.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 21, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

October 10, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2022

Completed
Last Updated

June 24, 2022

Status Verified

June 1, 2022

Enrollment Period

1.7 years

First QC Date

August 3, 2020

Last Update Submit

June 23, 2022

Conditions

Keywords

virtual realitygaitoptic flow

Outcome Measures

Primary Outcomes (11)

  • 3D kinematic measurements lower limb

    Kinematic data (i.e. movement amplitudes of the bilateral hip, knee and ankle joint in degrees) of the lower limbs during treadmill walking will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • 3D kinematic measurements upper limb (arm swing)

    Kinematic data (i.e. movement amplitudes of the bilateral shoulder, elbow and wrist joint in degrees) of the upper limb during treadmill walking will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz. With these data, information about the arm swing during walking will be obtained.

    through study completion, an average of 1 year

  • 3D kinetic measurements lower limb

    Kinetic data (i.e. forces, moments and powers of the bilateral hip, knee and ankle joint in respectively Newton, Newton-meters and Watt) of the lower limbs during treadmill walking will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • Walking speed

    Walking speed (m/s) will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • Cadence

    Cadence (steps/min) will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • Step length

    Step length (cm) will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • Step time

    Step time (s) will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • Swing - and stance time

    Swing and stance time (s) will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • Single - and double limb support period

    Single and double limb support period (% gait cycle) will be recorded continuously with the use of a 10-camera VICON Vero 1.3 system at 100 Hz.

    through study completion, an average of 1 year

  • Lower limb muscles activity

    Muscle activity of the lower limb muscles (bilateral: M. rectus femoris, M. vastus lateralis, M. biceps femoris, M. tibialis anterior, M. gastrocnemius medialis) will be recorded continuously during treadmill walking with the use of surface electrodes. Signals will be recorded with the wireless EMG system Delsys Tigno (16 channels).

    through study completion, an average of 1 year

  • Upper limb muscles activity

    Muscle activity of the upper limb muscles (bilateral: M. deltoideus anterior part, M. deltoideus posterior part, M. latissimus dorsi) will be recorded continuously during treadmill walking with the use of surface electrodes. Signals will be recorded with the wireless EMG system Delsys Tigno (16 channels).

    through study completion, an average of 1 year

Secondary Outcomes (4)

  • Simulator Sickness Questionnaire

    through study completion, an average of 1 year

  • Igroup Presence Questionnaire

    through study completion, an average of 1 year

  • Visual Analogue Scale

    through study completion, an average of 1 year

  • Number of falls or stumbles

    through study completion, an average of 1 year

Study Arms (1)

VR-enhanced treadmill walking

EXPERIMENTAL

Participants will be tested during 2 sessions of VR-enhanced treadmill walking.

Other: Walking with different optic flow speeds with 2 different VR devices

Interventions

Participants will perform 2 sessions of VR-enhanced treadmill walking. One session with the GRAIL system (semi-immersive) and the other session with a fully immersive head-mounted display (Oculus Rift S). In both sessions, the speed of the optic flow will be manipulated: equal to, 2 times faster and 2 times slower than the participant's comfortable walking speed.

VR-enhanced treadmill walking

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with stroke (as defined by the World Health Organization)
  • stroke onset ≥ 3 months
  • ambulatory with an impaired gait pattern (FAC-score 2, 3 or 4)
  • ability to walk on a treadmill for 4x8 minutes without bodyweight support
  • adult (≥ 18 years)
  • ability to signal pain, fear and discomfort
  • ability to give informed consent

You may not qualify if:

  • other neurological deficits than stroke leading to impaired gait (e.g. Parkinson's disease, multiple sclerosis)
  • comorbidities (e.g. COPD, severe osteoporosis, cardiovascular instability)
  • visual and/or vestibular disorders that can interfere with the VR
  • uncontrolled spasticity significantly interfering with the movement of the lower extremities (Modified Ashworth Scale \> 2)
  • acute medical illness
  • communicative/cognitive problems leading to the inability to understand and carry out instructions
  • severe unilateral spatial neglect
  • ≥ 18 years of age
  • normal or corrected-to-normal vision with glasses or contact lenses,
  • no locomotion impairments
  • having a significant lower extremity injury during the last two years that might affect their gait
  • having any type of vestibular/visual deficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emma De Keersmaecker

Brussels, 1090, Belgium

Location

Related Publications (1)

  • De Keersmaecker E, Van Bladel A, Zaccardi S, Lefeber N, Rodriguez-Guerrero C, Kerckhofs E, Jansen B, Swinnen E. Virtual reality-enhanced walking in people post-stroke: effect of optic flow speed and level of immersion on the gait biomechanics. J Neuroeng Rehabil. 2023 Sep 25;20(1):124. doi: 10.1186/s12984-023-01254-0.

MeSH Terms

Conditions

Stroke

Interventions

Walking

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Eva Swinnen, Prof. Ph.D

    Vrije Universiteit Brussel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 3, 2020

First Posted

August 21, 2020

Study Start

October 10, 2020

Primary Completion

June 23, 2022

Study Completion

June 23, 2022

Last Updated

June 24, 2022

Record last verified: 2022-06

Locations